SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by MeadowBrook Investment Advisors LLC

MeadowBrook Investment Advisors LLC trimmed its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,905 shares of the exchange traded fund’s stock after selling 255 shares during the period. SPDR S&P Biotech ETF comprises 1.3% of MeadowBrook Investment Advisors LLC’s holdings, making the stock its 18th largest position. MeadowBrook Investment Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,473,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of XBI. Healthcare of Ontario Pension Plan Trust Fund raised its holdings in SPDR S&P Biotech ETF by 30.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after purchasing an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. lifted its position in shares of SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock valued at $106,158,000 after buying an additional 18,202 shares in the last quarter. Jane Street Group LLC grew its stake in SPDR S&P Biotech ETF by 68.7% in the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock valued at $91,197,000 after acquiring an additional 391,333 shares during the period. Bessemer Group Inc. increased its holdings in SPDR S&P Biotech ETF by 1.7% in the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after acquiring an additional 15,794 shares in the last quarter. Finally, Employees Retirement System of Texas lifted its holdings in SPDR S&P Biotech ETF by 40.8% during the second quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after purchasing an additional 174,857 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock traded down $1.02 on Thursday, reaching $98.99. 2,407,165 shares of the company were exchanged, compared to its average volume of 9,311,933. SPDR S&P Biotech ETF has a 1 year low of $69.32 and a 1 year high of $105.47. The business has a 50-day moving average price of $99.07 and a 200 day moving average price of $95.98. The company has a market cap of $7.55 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.